These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 7095372)

  • 1. Haloperidol-induced chronic cholestatic liver disease.
    Dincsoy HP; Saelinger DA
    Gastroenterology; 1982 Sep; 83(3):694-700. PubMed ID: 7095372
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Importance of liver puncture biopsy and endoscopic retrograde cholangiography in patients with chronic anicteric unexplained cholestasis. A retrospective study in 79 patients].
    Sapey T; Turlin B; Canva-Delcambre V; Mendler MH; Deugnier Y; Brissot P; Guyader D
    Gastroenterol Clin Biol; 1999 Feb; 23(2):178-85. PubMed ID: 10353011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cholestatic liver disease with ductopenia (vanishing bile duct syndrome) after administration of clindamycin and trimethoprim-sulfamethoxazole.
    Altraif I; Lilly L; Wanless IR; Heathcote J
    Am J Gastroenterol; 1994 Aug; 89(8):1230-4. PubMed ID: 8053440
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Intrahepatic cholestasis in hyperthyroidism].
    Raviolo P; Rizzetto M; Tabone M; De La Pierre M; Recchia S; Verme G
    Recenti Prog Med; 1991 Jun; 82(6):319-23. PubMed ID: 1924986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vanishing bile duct syndrome: a possible mechanism for intrahepatic cholestasis in Hodgkin's lymphoma.
    Hubscher SG; Lumley MA; Elias E
    Hepatology; 1993 Jan; 17(1):70-7. PubMed ID: 7678577
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vanishing bile duct syndrome temporally associated with ibuprofen use.
    Alam I; Ferrell LD; Bass NM
    Am J Gastroenterol; 1996 Aug; 91(8):1626-30. PubMed ID: 8759674
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyperbilirubinemia and cholestatic liver injury in hepatitis C-infected liver transplant recipients.
    Cotler SJ; Taylor SL; Gretch DR; Bronner MP; Rizk R; Perkins JD; Carithers RL
    Am J Gastroenterol; 2000 Mar; 95(3):753-9. PubMed ID: 10710070
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methimazole-associated cholestatic liver injury: case report and brief literature review.
    Schmidt G; Börsch G; Müller KM; Wegener M
    Hepatogastroenterology; 1986 Dec; 33(6):244-6. PubMed ID: 3804181
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progressive intrahepatic cholestasis of infancy and childhood. A clinicopathological study of patient surviving to the age of 18 years.
    Jones EA; Rabin L; Buckley CH; Webster GK; Owens D
    Gastroenterology; 1976 Oct; 71(4):675-82. PubMed ID: 955355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Focal destructive cholangiopathy associated with amoxycillin/clavulanic acid (Augmentin).
    Ryley NG; Fleming KA; Chapman RW
    J Hepatol; 1995 Sep; 23(3):278-82. PubMed ID: 8550991
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prolonged cholestasis and progressive hepatic fibrosis following imipramine therapy.
    Horst DA; Grace ND; LeCompte PM
    Gastroenterology; 1980 Sep; 79(3):550-4. PubMed ID: 7429116
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ABCB4 heterozygous gene mutations associated with fibrosing cholestatic liver disease in adults.
    Ziol M; Barbu V; Rosmorduc O; Frassati-Biaggi A; Barget N; Hermelin B; Scheffer GL; Bennouna S; Trinchet JC; Beaugrand M; Ganne-Carrié N
    Gastroenterology; 2008 Jul; 135(1):131-41. PubMed ID: 18482588
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic active hepatitis with cholestatic features. II. A histopathological study.
    Shouval D; Eliakim M; Levij IS
    Am J Gastroenterol; 1979 Nov; 72(5):551-5. PubMed ID: 532798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatic sarcoidosis. Clinicopathologic features in 100 patients.
    Devaney K; Goodman ZD; Epstein MS; Zimmerman HJ; Ishak KG
    Am J Surg Pathol; 1993 Dec; 17(12):1272-80. PubMed ID: 8238735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic graft-versus-host disease of the liver: presentation as an acute hepatitis.
    Strasser SI; Shulman HM; Flowers ME; Reddy R; Margolis DA; Prumbaum M; Seropian SE; McDonald GB
    Hepatology; 2000 Dec; 32(6):1265-71. PubMed ID: 11093733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cholestatic jaundice induced by D-penicillamine and oral steroid contraceptive in progressive systemic sclerosis (author's transl)].
    Wozel G; Julius U
    Dtsch Z Verdau Stoffwechselkr; 1982; 42(2-3):85-93. PubMed ID: 6179735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Variant forms of cholestatic diseases involving small bile ducts in adults.
    Kim WR; Ludwig J; Lindor KD
    Am J Gastroenterol; 2000 May; 95(5):1130-8. PubMed ID: 10811317
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Small bile duct abnormalities and chronic intrahepatic cholestasis in Behçet's syndrome.
    Hisaoka M; Haratake J; Nakamura T
    Hepatogastroenterology; 1994 Jun; 41(3):267-70. PubMed ID: 7959551
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Intrahepatic cholestasis in chronic liver disease].
    Roda E; Pezzoli A; Fusaroli P; Fabbri C; Jaboli F; Marchetto S; Azzaroli F; Mazzella G
    Ann Ital Med Int; 1996 Oct; 11 Suppl 2():48S-52S. PubMed ID: 9004820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histopathology of cholestasis.
    Desmet VJ
    Verh Dtsch Ges Pathol; 1995; 79():233-40. PubMed ID: 8600686
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.